期刊文献+

PI3K p110α在宫颈病变中的表达研究 被引量:7

Study of PI3K p110α Expression in Cervical Lesions
原文传递
导出
摘要 目的研究PI3K p110α蛋白在宫颈上皮内瘤变和宫颈癌中的表达及其与临床病理特征的关系。方法应用ElivisionTMSuper免疫组化法检测40例正常宫颈、31例CINⅠ、33例CINⅡ、35例CINⅢ和41例宫颈癌石蜡标本中PI3K p110α的表达,比较各组间的差别及与患者临床病理特征的关系。结果①PI3K p110α在正常宫颈、CINⅠ、CINⅡ、CINⅢ及宫颈癌中的阳性率依次为0.0%、19.4%、57.6%、65.7%、80.5%。②比较正常宫颈与CINⅠ之间(χ2=8.451,P=0.004)及CINⅠ与CINⅡ之间(χ2=9.810,P=0.002),PI3K p110α阳性率差异有统计学意义;CINⅡ组与CINⅢ组之间(χ2=0.476,P=0.490)及CINⅢ与宫颈癌之间(χ2=2.125,P=0.145)比较,随着分期的增加呈上升趋势,但差异无统计学意义。③PI3K p110α在LSIL和HSIL中的阳性率分别是19.4%和61.8%,差异有统计学意义(χ2=15.333,P=0.000),可将其视为宫颈LSIL与HSIL间的辅助鉴别指标。④PI3K p110α蛋白表达与宫颈癌临床分期、组织分化程度及有无淋巴结转移有关(P<0.05)。结论 PI3K p110α在除正常宫颈组织外的各级宫颈病变组织中均呈阳性表达,抑制其活性可能为宫颈癌的治疗提供新靶点。 Objective To study the clinical pathological significance of PI3K p110α expression in cervical cancer(CC) and cervical intraeptithelial neoplasia (CIN). Methods We detected the expression of PI3K p110α in 40 cases of normal cervix,31 cases of CINⅠ,33 cases of CINⅡ,35 cases of CINⅢ and 41 cases of CC by ElivisionTM Super immunohistochemistry,and analyzed the relationship between the expression and clinicopathological characteristics. Results The positive ratio of PI3K p110α in normal cervix,CINⅠ,CINⅡ,CINⅢ and CC was 0.0%,19.4%,57.6%,65.7% and 80.5%,respectively.There were statistically significant differences in the positive ratio of PI3K p110α expression between normal cervical epithelial tissue and CINⅠ(χ2=8.451,P=0.004),also between CIN I and CINⅡ(χ2=9.810,P=0.002).No statistically significant difference was found in the positive ratio of PI3K p110α expression between CIN Ⅱ and CIN Ⅲ(χ2=0.476,P=0.490),also between CIN Ⅲ and cervical cancer(χ2=2.125,P=0.145),however,the PI3K p110α expression showed an ascending tendency with the increasing histological stage.Positive ratio of PI3K p110α in LSIL and HSIL was 19.4% and 61.8% respectively,and the difference was statistically significant(χ2=15.333,P=0.000).PI3K p110α may be a good ancillary index to screen HSIL of cervix.There was a positive correlation between PI3K p110α expression and clinicopathological characteristics. Conclusions Excepting normal cervical tissue,PI3K p110α expression is positive in all stages of cervical lesions.Inhibiting PI3K p110α activity may provide a new target for cervical cancer treatment.
出处 《实用预防医学》 CAS 2011年第3期417-419,共3页 Practical Preventive Medicine
关键词 PIK3CA PI3Kp110α 宫颈上皮内瘤变 宫颈癌 PIK3CA PI3K p110α Cervical intraeptithelial neoplasia Cervical cancer
  • 相关文献

参考文献8

  • 1World Health Organization. Comprehensive cervical cancer control - A guide to essential practice[R]. 2006. 16 - 17.
  • 2Fattaneh A. Tavassoli, Peter Devilee.乳腺及生殖器官肿瘤病理学和遗传学[M].第1版.北京:人民卫生出版社,2006.
  • 3王洪艳,崔竹梅,刘湘萍,隋爱华,杨堃,孙显路.原癌基因PIK3CA在宫颈癌组织中的表达及意义[J].青岛大学医学院学报,2008,44(1):48-50. 被引量:7
  • 4Carlota Costa, Blanca Espinet, Miguel A, et al. Analysis of gene status in cervical dysplastic lesions and squarnous cell carcinoma using tissue microarrays[J ]. Histol Histopathol, 2009, 24 : 821 - 829.
  • 5Samules Y, Wang Z, Bardelli A, et al. High frequency of mutation of the PIK3CA gene in human cancers[J]. Seienee, 2004, 304- 554.
  • 6Ma YY, Wei SJ, Lin YC, et al. PIK3CA a5 a oncogene in cervical caneer[J]. Oneogene, 2000, 19:2739-2744.
  • 7Zhang A, Maner S, Betz R, et al. Genetic alterations in cervical carci- nomas: pectral lowlevel amplifications of oncogenes are associated with human papillomavirus infection[J]. Int J Cancer, 2002, 101 : 427 -433.
  • 8Huang KF, Lee WY, Huang SC, et al. Chromosomal gain of 3q and loss of 1 lq often associated with nodal metastasis in carly stage cervical squamous cell carcinorna[J ]. J Formos Med Assoc, 2007,. 106 : 894 - 902.

二级参考文献7

  • 1闫凤霞,于向民,潘晓亮,徐元芹.消瘿强肌汤治疗甲状腺功能亢进性肌病大鼠的形态学观察[J].青岛大学医学院学报,2007,43(1):40-42. 被引量:5
  • 2WOLF J K, RAMIREZ P T. The molecular biology of cervical cancer[J]. Cancer Invest, 2001,19:621-629.
  • 3KANG S, BADER A G, VOGT P K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic[J]. Proc Natl Acad Sci USA, 2005,102:802-807.
  • 4SHAYESTCH L, LU Y, KUO W L, et al. PIK3CA is implicated as an oncogen in ovarian cancer[J]. Nature Genet, 1999,21:99-03.
  • 5MA Y Y, WEI S J, LIN Y C, et al. PIK3CA as an oncogen in cervical cancer[J]. Oncogene, 2000,19:2739-2744.
  • 6SAMUELS Y, WANG Z, BARDELLI A, et al. High frequency of mutation of the PIK3CA gene in human cancers[J]. Science, 2004,304(5670):554.
  • 7GOTO T, TAKANO M, SASA H, et al. Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesisrelated marker on liquidbased cytology in cervical intraepithelial neoplasia[J]. Oncol Rep, 2006,15:387-391.

共引文献6

同被引文献67

  • 1刘杰,许畅,邱叶贝,曹建国,杨剑锋,张坚松.芹菜素抑制Ck2下调p-STAT蛋白表达抑制HeLa源性球细胞自我更新[J].湖南师范大学学报(医学版),2019,16(6):1-3. 被引量:3
  • 2郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 3孙晓杰,黄常志.PI3K-Akt信号通路与肿瘤[J].世界华人消化杂志,2006,14(3):306-311. 被引量:80
  • 4夏曙,于世英.抑制PI3K/Akt信号转导通路提高化疗效果的实验研究[J].肿瘤,2006,26(4):311-313. 被引量:21
  • 5Correnti M,Medina F,Cavazza ME,et al.Human papillomavimrus (HPV) type distribution in cervical carcinoma,low-grade and high-grade squamous intraepithelial lesions in Venezuelan women[J].Gynecol Oncol,2011,121 (3):527-531.
  • 6Lin M,Yang LY,LI LJ,et al.Genital human papillomavirus screening by gene chip in Chinese women of Guandong province[J].Aust N Z J obstet Gynaecol,2008,48:189-194.
  • 7Huang LW,Lin YH,Pan HS,et al.Human papillomavirus genotyping as a predictor of high grade cervical dysplasia in woman with midly cytologic abnormalities:a-two-year follow-up report[J].Diagn Cytopathol,2012,40(8):673-677.
  • 8Guyot A,Karim S,Kyi MS,et al.Evaluation of adjunction HPV testing by hybrid captuerll in woman with minor cytological abnormalities for CIN2/3 and cost comparison with col.poscopy[J].BMC Infect DIs,2003,3:23.
  • 9Tanaka H,Yoshida M,Tanimura H,et al.The selective class Ⅰ PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations[J].Clin Cancer Res,2011,17(10):3272-3281.
  • 10German S,Aslam HM,Saleem S,et al.Carcinogenesis of PIK3CA[J].Hered Cancer Clin Pract,2013,11(1):5.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部